Skip to main content
Top
Published in: Cancer Imaging 1/2020

Open Access 01-12-2020 | Gastric Cancer | Research article

Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer

Authors: Xiao-Xiao Wang, Yi Ding, Si-Wen Wang, Di Dong, Hai-Lin Li, Jian Chen, Hui Hu, Chao Lu, Jie Tian, Xiu-Hong Shan

Published in: Cancer Imaging | Issue 1/2020

Login to get access

Abstract

Background

Preoperative prediction of the Lauren classification in gastric cancer (GC) is very important to the choice of therapy, the evaluation of prognosis, and the improvement of quality of life. However, there is not yet radiomics analysis concerning the prediction of Lauren classification straightly. In this study, a radiomic nomogram was developed to preoperatively differentiate Lauren diffuse type from intestinal type in GC.

Methods

A total of 539 GC patients were enrolled in this study and later randomly allocated to two cohorts at a 7:3 ratio for training and validation. Two sets of radiomic features were derived from tumor regions and peritumor regions on venous phase computed tomography (CT) images, respectively. With the least absolute shrinkage and selection operator logistic regression, a combined radiomic signature was constructed. Also, a tumor-based model and a peripheral ring-based model were built for comparison. Afterwards, a radiomic nomogram integrating the combined radiomic signature and clinical characteristics was developed. All the models were evaluated regarding classification ability and clinical usefulness.

Results

The combined radiomic signature achieved an area under receiver operating characteristic curve (AUC) of 0.715 (95% confidence interval [CI], 0.663–0.767) in the training cohort and 0.714 (95% CI, 0.636–0.792) in the validation cohort. The radiomic nomogram incorporating the combined radiomic signature, age, CT T stage, and CT N stage outperformed the other models with a training AUC of 0.745 (95% CI, 0.696–0.795) and a validation AUC of 0.758 (95% CI, 0.685–0.831). The significantly improved sensitivity of radiomic nomogram (0.765 and 0.793) indicated better identification of diffuse type GC patients. Further, calibration curves and decision curves demonstrated its great model fitness and clinical usefulness.

Conclusions

The radiomic nomogram involving the combined radiomic signature and clinical characteristics holds potential in differentiating Lauren diffuse type from intestinal type for reasonable clinical treatment strategy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef
2.
go back to reference Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64(1):31–49.CrossRef Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64(1):31–49.CrossRef
3.
go back to reference Chen Y-C, Fang W-L, Wang R-F, Liu C-A, Yang M-H, Lo S-S, et al. Clinicopathological variation of Lauren classification in gastric cancer. Pathol Oncol Res. 2016;22(1):197–202.CrossRef Chen Y-C, Fang W-L, Wang R-F, Liu C-A, Yang M-H, Lo S-S, et al. Clinicopathological variation of Lauren classification in gastric cancer. Pathol Oncol Res. 2016;22(1):197–202.CrossRef
4.
go back to reference Ma L, Xu X, Zhang M, Zheng S, Zhang B, Zhang W, et al. Dynamic contrast-enhanced MRI of gastric cancer: correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis. Magn Reson Imaging. 2017;37:27–32.CrossRef Ma L, Xu X, Zhang M, Zheng S, Zhang B, Zhang W, et al. Dynamic contrast-enhanced MRI of gastric cancer: correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis. Magn Reson Imaging. 2017;37:27–32.CrossRef
5.
go back to reference Liu S, Liu S, Ji C, Zheng H, Pan X, Zhang Y, et al. Application of CT texture analysis in predicting histopathological characteristics of gastric cancers. Eur Radiol. 2017;27(12):4951–9.CrossRef Liu S, Liu S, Ji C, Zheng H, Pan X, Zhang Y, et al. Application of CT texture analysis in predicting histopathological characteristics of gastric cancers. Eur Radiol. 2017;27(12):4951–9.CrossRef
6.
go back to reference Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, Van Stiphout RG, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–6.CrossRef Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, Van Stiphout RG, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–6.CrossRef
7.
go back to reference Dong D, Fang M-J, Tang L, Shan X-H, Gao J-B, Giganti F, et al. Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multi-center study. Ann Oncol. 2020;31(7):912–20.CrossRef Dong D, Fang M-J, Tang L, Shan X-H, Gao J-B, Giganti F, et al. Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multi-center study. Ann Oncol. 2020;31(7):912–20.CrossRef
8.
go back to reference Li J, Dong D, Fang M, Wang R, Tian J, Li H, et al. Dual-energy CT–based deep learning radiomics can improve lymph node metastasis risk prediction for gastric cancer. Eur Radiol. 2020;30(4):2324–33.CrossRef Li J, Dong D, Fang M, Wang R, Tian J, Li H, et al. Dual-energy CT–based deep learning radiomics can improve lymph node metastasis risk prediction for gastric cancer. Eur Radiol. 2020;30(4):2324–33.CrossRef
9.
go back to reference Dong D, Tang L, Li Z-Y, Fang M-J, Gao J-B, Shan X-H, et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol. 2019;30(3):431–8.CrossRef Dong D, Tang L, Li Z-Y, Fang M-J, Gao J-B, Shan X-H, et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol. 2019;30(3):431–8.CrossRef
10.
go back to reference Zhang W, Fang M, Dong D, Wang X, Ke X, Zhang L, et al. Development and validation of a CT-based radiomic nomogram for preoperative prediction of early recurrence in advanced gastric cancer. Radiother Oncol. 2020;145:13–20.CrossRef Zhang W, Fang M, Dong D, Wang X, Ke X, Zhang L, et al. Development and validation of a CT-based radiomic nomogram for preoperative prediction of early recurrence in advanced gastric cancer. Radiother Oncol. 2020;145:13–20.CrossRef
11.
go back to reference Zhang L, Dong D, Zhang W, Hao X, Fang M, Wang S, et al. A deep learning risk prediction model for overall survival in patients with gastric Cancer: a multicenter study. Radiother Oncol. 2020;150:73–80.CrossRef Zhang L, Dong D, Zhang W, Hao X, Fang M, Wang S, et al. A deep learning risk prediction model for overall survival in patients with gastric Cancer: a multicenter study. Radiother Oncol. 2020;150:73–80.CrossRef
12.
go back to reference Wang S, Feng C, Dong D, Li H, Zhou J, Ye Y, et al. Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study. Med Phys. 2020;47(10):4862–71.CrossRef Wang S, Feng C, Dong D, Li H, Zhou J, Ye Y, et al. Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study. Med Phys. 2020;47(10):4862–71.CrossRef
13.
go back to reference Nisha N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17(9):559–72.CrossRef Nisha N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17(9):559–72.CrossRef
14.
go back to reference Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016;18(1):84.CrossRef Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016;18(1):84.CrossRef
15.
go back to reference Maonan W, Jingzhou Z, Lishen Z, Fang W, Yu L, Yingfeng W, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761–73.CrossRef Maonan W, Jingzhou Z, Lishen Z, Fang W, Yu L, Yingfeng W, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761–73.CrossRef
16.
go back to reference Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 2018;19(9):1180–91.CrossRef Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 2018;19(9):1180–91.CrossRef
17.
go back to reference Zwanenburg A, Leger S, Vallières M, Löck S, Initiative FBS. Image biomarker standardisation initiative; 2016. Zwanenburg A, Leger S, Vallières M, Löck S, Initiative FBS. Image biomarker standardisation initiative; 2016.
18.
go back to reference Huang Y-q, Liang C-h, He L, Tian J, Liang C-S, Chen X, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer 2016. Huang Y-q, Liang C-h, He L, Tian J, Liang C-S, Chen X, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer 2016.
19.
go back to reference Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Info Decision Making. 2008;8(1):53.CrossRef Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Info Decision Making. 2008;8(1):53.CrossRef
20.
go back to reference Pencina MJ, Fine JP, D'Agostino RB Sr. Discrimination slope and integrated discrimination improvement–properties, relationships and impact of calibration. Stat Med. 2017;36(28):4482–90.CrossRef Pencina MJ, Fine JP, D'Agostino RB Sr. Discrimination slope and integrated discrimination improvement–properties, relationships and impact of calibration. Stat Med. 2017;36(28):4482–90.CrossRef
21.
go back to reference Qiu M-Z, Shi S-M, Chen M, Wang J, Wu Q-N, Sheng H, et al. Comparison of HER2 and lauren classification between biopsy and surgical resection samples, primary and metastatic samples of gastric cancer. J Cancer. 2017;8(17):3531.CrossRef Qiu M-Z, Shi S-M, Chen M, Wang J, Wu Q-N, Sheng H, et al. Comparison of HER2 and lauren classification between biopsy and surgical resection samples, primary and metastatic samples of gastric cancer. J Cancer. 2017;8(17):3531.CrossRef
22.
go back to reference Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy: American joint committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88(4):921–32.CrossRef Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy: American joint committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88(4):921–32.CrossRef
23.
go back to reference Satoh A, Shuto K, Okazumi S, Ohira G, Natsume T, Hayano K, et al. Role of perfusion CT in assessing tumor blood flow and malignancy level of gastric Cancer. Dig Surg. 2010;27(4):253–60.CrossRef Satoh A, Shuto K, Okazumi S, Ohira G, Natsume T, Hayano K, et al. Role of perfusion CT in assessing tumor blood flow and malignancy level of gastric Cancer. Dig Surg. 2010;27(4):253–60.CrossRef
25.
go back to reference M-z Q, M-y C, D-s Z, Wang Z-q, Wang D-s, Y-h L, et al. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. J Transl Med. 2013;11(1):58.CrossRef M-z Q, M-y C, D-s Z, Wang Z-q, Wang D-s, Y-h L, et al. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. J Transl Med. 2013;11(1):58.CrossRef
Metadata
Title
Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer
Authors
Xiao-Xiao Wang
Yi Ding
Si-Wen Wang
Di Dong
Hai-Lin Li
Jian Chen
Hui Hu
Chao Lu
Jie Tian
Xiu-Hong Shan
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Cancer Imaging / Issue 1/2020
Electronic ISSN: 1470-7330
DOI
https://doi.org/10.1186/s40644-020-00358-3

Other articles of this Issue 1/2020

Cancer Imaging 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine